Finnish Study Evaluates HPV Test as Primary Cervical Cancer Screening Tool

Nov 10, 2009

NEW YORK (GenomeWeb News) – Genetic testing for human papillomavirus or HPV followed by conventional cytology in HPV-positive women may be an effective primary cervical cancer screening method — particularly in women 35 or older — according to a paper published online today in the Journal of the National Cancer Institute.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

Finnish Study Evaluates HPV Test as Primary Cervical Cancer Screening Tool

To read the full story....

Breaking News

NeuMoDx Molecular, Sentinel Diagnostics Partner for MDx Development

PAK4 Inhibition Increases Anti-PD-1 Response in Mouse Models Prompting Phase I Trial

Researchers Use Machine Learning to Map Functional Relevance of Human Phosphoproteome

Biocept Prices $10M Public Offering of Stocks, Warrants

Top Five Articles on GenomeWeb Last Week: Veritas Genetics, Illumina, GenomeWeb Index, and More

CRISPR Researchers Develop System to Catalog Wide Range of Gene Editing Outcomes

Recent Headlines from
Precision Oncology News

Classification Algorithm Divides Pancreatic Cancer Patients by Likely Treatment Response, Outcome

Oncologists, Patient Groups Eagerly Await Access to KRAS Inhibitors Based on Promising Early Data

Oncolytic Viruses May Help Cancer Patients Overcome Resistance to Immunotherapy, Research Shows

Mayo Clinic Researchers Plan to Launch Trials for Preventative Breast Cancer Vaccine in 2020

Q&A: The Parker Institute's Theresa LaVallee on the Path Forward for Precision Immuno-Oncology

The Scan

Project to Discuss Race and Genetics in Class

Taking It All On

PLOS Papers on ASD-Related Syndrome, Twin Gut Microbiomes, Zika Virus Evolution

Unexpected Close

Featured White Papers

Sponsorships